Evidence map›Paper›PMID 39535623›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Comparison of molecular testing methods for diagnosing non-tuberculous mycobacterial infections.

Leilei Wang, Yu Chen, Qingqing Wang, Jue Pan, Rong Bao, Wenting Jin, Yumeng Yao, Tingting Fang, Na Li, Sichun Luan and 9 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. DisseminatedInfection and drug resistance · 2026
    Article
  4. ChronicInfection and drug resistance · 2026
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Leilei Wang *Department of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Yu Chen *Department of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Qingqing Wang *Department of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Jue PanDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Rong BaoDepartment of Microbiology, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Wenting JinDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Yumeng YaoDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Tingting FangDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Na LiDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Sichun LuanDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Xiaoyu YinDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Le QinDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Chunmei ZhouDepartment of Microbiology, Zhongshan Hospital of Fudan University, Shanghai, 200032, China.
Pengyan ZhuGuangzhou KingCreate Biotechnology Co., Ltd, Guangzhou, 510000, China.
Aisi FuShanghai Dgensee Medical Technology Co., Ltd, Shanghai, 200032, China.
Bin PangShanghai Dgensee Medical Technology Co., Ltd, Shanghai, 200032, China.
Yuan JiDepartment of Pathology, Zhongshan Hospital of Fudan University, Shanghai, 200032, China. ji.yuan@zs-hospital.sh.cn.
Bijie HuDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China. hu.bijie@zs-hospital.sh.cn.
Qing MiaoDepartment of Infectious Diseases, Zhongshan Hospital of Fudan University, Shanghai, 200032, China. miao.qing@zs-hospital.sh.cn.

Funding

Special Program for Clinical Research of Zhongshan Hospital Affiliated to Fudan University ZSLCYJ202309
6 · The paper itself

Abstract

purposesRapid and accurate identification of non-tuberculous mycobacteria (NTM) is crucial yet challenging, promoting the development of novel molecular techniques such as amplification-based targeted high-throughput sequencing and metagenomic unbiased high-throughput sequencing. We aimed to evaluate the diagnostic value of these molecular techniques for NTM infection.

methodsA total of 115 clinical specimens from patients with confirmed NTM infection were subjected to multiplex polymerase chain reaction detection techniques (multi-PCR), metagenomic Next-Generation Sequencing (mNGS), targeted Next-Generation Sequencing (tNGS), and targeted Nanopore sequencing (tNanopore). Positivity rates and species identification were compared among these techniques.

resultsThe sensitivity of mNGS, tNGS, and multi-PCR in NTM-infection diagnosis was 44.3%, 42.6%, and 36.5%, respectively, while the sensitivity of the three methods in combination increased to 54.8%. The pathogen identification results of mNGS, tNGS and multi-PCR were matched in 80.6% (25/31) samples at the species level, among which 14 samples (45.2%) was completely matched at the subspecies level. The results of tNanopore, tNGS and mNGS at the species level were completely matched in 73.3% (22/30) samples.

conclusionsThese molecular assays demonstrated comparable performance in precisely identifying NTM species in clinical specimens, showing their promising potential as efficient and alternative tools for the rapid diagnosis of NTM disease.

Indexed as

Molecular Diagnostic TechniquesMycobacterium Infections, NontuberculousNontuberculous MycobacteriaAdultAgedAged, 80 and overFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMultiplex Polymerase Chain ReactionNanopore SequencingSensitivity and SpecificityIdentificationMetagenomic next-generation sequencingMulti-PCRNon-tuberculous mycobacteriaTargeted Nanopore sequencingTargeted next-generation sequencing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.